




Searching News Database: Apotex
HSMN NewsFeed - 14 Jun 2016
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
HSMN NewsFeed - 10 Sep 2014
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
Mylan to Acquire U.S. Rights to Arixtra(R) (fondaparinux sodium) Injection from Aspen
HSMN NewsFeed - 24 Sep 2013
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of Savella(R) Patents
HSMN NewsFeed - 14 Sep 2011
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox(R) (deferiprone) Approval
HSMN NewsFeed - 19 Jun 2007
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
HSMN NewsFeed - 10 May 2007
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
HSMN NewsFeed - 24 Apr 2007
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 22 Mar 2007
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case
HSMN NewsFeed - 12 Mar 2007
Cangene receives an approvable letter from the FDA for human growth hormone
Cangene receives an approvable letter from the FDA for human growth hormone
HSMN NewsFeed - 27 Dec 2006
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
Dr. Reddy's Announces Final Approval of Ondansetron Tablets with 180-Days of Marketing Exclusivity
Additional items found! 44

Members Archive contains
44 additional stories matching:
Apotex
(Password required)
Apotex
(Password required)